Completed NA INTERVENTIONAL 2-arm NCT01379001

Assessment of Cholinergic and Cognitive Function Using Pharmacologic ASL-Perfusion MRI

Sponsor: Hebrew SeniorLife

Interventions Donepezil Placebo Scopolamine

Updated 6 times since 2017 Last updated: Jan 3, 2013 Started: Jul 31, 2008 Primary completion: Jan 31, 2013 Completion: Jan 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Cholinergic Function and is currently completed. Hebrew SeniorLife leads this study, which shows 6 recorded versions since 2008 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Feb 2021 — Jul 2024 [monthly]

Completed NA
Jan 2021 — Feb 2021 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Jul 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hebrew SeniorLife

Data source: Hebrew SeniorLife

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.